These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 24917012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
    Kawai H, Sugimoto R, Miyauchi S, Yoshida R, Waki N, Hirayama S, Ishizaki M, Nishi H, Yamashita K.
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
    Morishita A, Mitsuhashi S, Fujisawa F, Hirano M, Kojima H.
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
    [Abstract] [Full Text] [Related]

  • 8. [A case of stage IV breast cancer with long-term partial response treated with tri-weekly paclitaxel plus bevacizumab].
    Okamoto A, Nakatsukasa K, Fujita Y, Sugimoto R, Sakaguchi K, Taguchi T.
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):343-6. PubMed ID: 25812504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A case of recurrent breast cancer with carcinomatous pleurisy responding to bevacizumab and paclitaxel therapy].
    Sato Y, Nakagawa T, Sato T, Nagahara M, Sugihara K.
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2387-9. PubMed ID: 24394121
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Responses to primary systemic therapy for breast cancer as assessed by hormone receptor and HER2 status].
    Hirano A, Shimizu T, Kamimura M, Ogura K, Kim N, Setoguchi Y, Okubo F, Kinoshita J, Ogawa K, Fujibayashi M.
    Gan To Kagaku Ryoho; 2011 May; 38(5):771-6. PubMed ID: 21566435
    [Abstract] [Full Text] [Related]

  • 17. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
    Torrisi R, Balduzzi A, Ghisini R, Rocca A, Bottiglieri L, Giovanardi F, Veronesi P, Luini A, Orlando L, Viale G, Goldhirsch A, Colleoni M.
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):667-72. PubMed ID: 18064460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY, Zhang P, Zhang BL, Wang X, Xu XZ, Zheng S, Wang JY, Cai RG, Yuan P, Ma F, Fan Y, Xu BH.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [Abstract] [Full Text] [Related]

  • 20. [A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].
    Miki M, Matsuo Y, Yoshida S, Tane K, Hirokaga K, Maekawa Y, Takao S.
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):1027-9. PubMed ID: 25132039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.